Molecular modeling
The potential mechanism by which RSV B I206M:Q209R substitutions increased nirsevimab potency in vitro was assessed using molecular modeling. The I206M substitution was not implicated in direct interaction with nirsevimab, and despite the extended methionine side chain, the substitution was structurally tolerated (Fig. 